Why the study?
Does systemic infusion of plasmin alter the evolution of myocardial infarction in experimental animals with coronary thrombi?
Does systemic infusion of plasmin alter the evolution of myocardial infarction in experimental animals with coronary thrombi?
Systemic infusion of plasmin may alter the evolution of early myocardial infarction in an experimental animal model of coronary thrombosis.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for plasmin in experimental MI; does not support clinical translation pending human trials.
Ruegsegger et al. (1959) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: